• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化婴儿气道微生物组的纵向发育。

Longitudinal development of the airway microbiota in infants with cystic fibrosis.

机构信息

National Heart and Lung Institute, Imperial College London, London, UK.

Department of Respiratory Paediatrics, Royal Brompton Hospital, London, UK.

出版信息

Sci Rep. 2019 Mar 26;9(1):5143. doi: 10.1038/s41598-019-41597-0.

DOI:10.1038/s41598-019-41597-0
PMID:30914718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6435666/
Abstract

The pathogenesis of airway infection in cystic fibrosis (CF) is poorly understood. We performed a longitudinal study coupling clinical information with frequent sampling of the microbiota to identify changes in the airway microbiota in infancy that could underpin deterioration and potentially be targeted therapeutically. Thirty infants with CF diagnosed on newborn screening (NBS) were followed for up to two years. Two hundred and forty one throat swabs were collected as a surrogate for lower airway microbiota (median 35 days between study visits) in the largest longitudinal study of the CF oropharyngeal microbiota. Quantitative PCR and Illumina sequencing of the 16S rRNA bacterial gene were performed. Data analyses were conducted in QIIME and Phyloseq in R. Streptococcus spp. and Haemophilus spp. were the most common genera (55% and 12.5% of reads respectively) and were inversely related. Only beta (between sample) diversity changed with age (Bray Curtis r = 0.15, P = 0.03). Staphylococcus and Pseudomonas were rarely detected. These results suggest that Streptococcus spp. and Haemophilus spp., may play an important role in early CF. Whether they are protective against infection with more typical CF micro-organisms, or pathogenic and thus meriting treatment needs to be determined.

摘要

气道感染在囊性纤维化(CF)中的发病机制尚不清楚。我们进行了一项纵向研究,将临床信息与频繁的微生物群采样相结合,以确定婴儿期气道微生物群的变化,这些变化可能是病情恶化的基础,并具有潜在的治疗靶向性。我们对通过新生儿筛查(NBS)诊断为 CF 的 30 名婴儿进行了为期两年的随访。采集了 241 份咽喉拭子作为下气道微生物群的替代物(研究访问之间的中位数为 35 天),这是 CF 口咽微生物群的最大纵向研究。对 16S rRNA 细菌基因进行定量 PCR 和 Illumina 测序。数据分析在 QIIME 和 R 中的 Phyloseq 中进行。链球菌属和嗜血杆菌属是最常见的属(分别占读数的 55%和 12.5%),且呈负相关。只有 beta(样本间)多样性随年龄而变化(Bray Curtis r=0.15,P=0.03)。葡萄球菌和假单胞菌很少被检测到。这些结果表明,链球菌属和嗜血杆菌属可能在 CF 的早期发挥重要作用。它们是对更典型的 CF 微生物感染具有保护作用,还是具有致病性且因此值得治疗,这需要进一步确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/7048eef230ee/41598_2019_41597_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/ac82829a994f/41598_2019_41597_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/ccdd789cdb8d/41598_2019_41597_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/7048eef230ee/41598_2019_41597_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/ac82829a994f/41598_2019_41597_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/ccdd789cdb8d/41598_2019_41597_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/6435666/7048eef230ee/41598_2019_41597_Fig3_HTML.jpg

相似文献

1
Longitudinal development of the airway microbiota in infants with cystic fibrosis.囊性纤维化婴儿气道微生物组的纵向发育。
Sci Rep. 2019 Mar 26;9(1):5143. doi: 10.1038/s41598-019-41597-0.
2
Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.使用多种采样方法评估囊性纤维化患者气道微生物群和炎症情况。
Ann Am Thorac Soc. 2015 Feb;12(2):221-9. doi: 10.1513/AnnalsATS.201407-310OC.
3
Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.儿童囊性纤维化上下呼吸道微生物组和宏基因组及其与肺部炎症的相关性。
PLoS One. 2019 Sep 19;14(9):e0222323. doi: 10.1371/journal.pone.0222323. eCollection 2019.
4
Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.囊性纤维化婴儿的粪便微生物组发生改变,从出生起与免疫编程相关的属减少。
J Bacteriol. 2019 Jul 24;201(16). doi: 10.1128/JB.00274-19. Print 2019 Aug 15.
5
Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis.哮喘与囊性纤维化患儿口咽菌群的比较。
Mediators Inflamm. 2017;2017:5047403. doi: 10.1155/2017/5047403. Epub 2017 Dec 27.
6
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.婴儿期囊性纤维化患者鼻咽微生物组的发育。
Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.
7
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.囊性纤维化气道微生物组在临床稳定期的测量。
Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.
8
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.早期囊性纤维化肺病患者的下呼吸道微生物组:一项纵向分析。
Thorax. 2017 Dec;72(12):1104-1112. doi: 10.1136/thoraxjnl-2016-209279. Epub 2017 Mar 9.
9
Comparison of the airway microbiota in children with chronic suppurative lung disease.儿童慢性化脓性肺病的气道微生物组比较。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001106.
10
Concordance between upper and lower airway microbiota in infants with cystic fibrosis.婴儿囊性纤维化上下呼吸道微生物群落的一致性。
Eur Respir J. 2017 Mar 29;49(3). doi: 10.1183/13993003.02235-2016. Print 2017 Mar.

引用本文的文献

1
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis.治疗性抗生素暴露对囊性纤维化婴儿口咽和粪便微生物群的影响。
Pediatr Pulmonol. 2025 Mar;60(3):e71024. doi: 10.1002/ppul.71024.
2
Early nasal microbiota and subsequent respiratory tract infections in infants with cystic fibrosis.囊性纤维化婴儿的早期鼻腔微生物群与随后的呼吸道感染
Commun Med (Lond). 2024 Nov 23;4(1):246. doi: 10.1038/s43856-024-00616-6.
3
Comparison of culture and PCR-DGGE methods to evaluate the airways of cystic fibrosis patients and determination of their antibiotic resistance profile.

本文引用的文献

1
Differences in the lower airway microbiota of infants with and without cystic fibrosis.囊性纤维化患儿与非囊性纤维化患儿下呼吸道微生物群的差异。
J Cyst Fibros. 2019 Sep;18(5):646-652. doi: 10.1016/j.jcf.2018.12.003. Epub 2018 Dec 21.
2
Comparison of the upper and lower airway microbiota in children with chronic lung diseases.比较儿童慢性肺部疾病患者的上、下呼吸道微生物群。
PLoS One. 2018 Aug 2;13(8):e0201156. doi: 10.1371/journal.pone.0201156. eCollection 2018.
3
Airway microbiota across age and disease spectrum in cystic fibrosis.
比较培养法和聚合酶链反应-变性梯度凝胶电泳(PCR-DGGE)法以评估囊性纤维化患者的气道并确定其抗生素耐药谱。
Iran J Microbiol. 2023 Dec;15(6):750-758. doi: 10.18502/ijm.v15i6.14135.
4
The presence of cystic fibrosis-related diabetes modifies the sputum microbiome in cystic fibrosis disease.囊性纤维化相关糖尿病的存在改变了囊性纤维化疾病中的痰微生物组。
Am J Physiol Lung Cell Mol Physiol. 2024 Feb 1;326(2):L125-L134. doi: 10.1152/ajplung.00219.2023. Epub 2023 Dec 12.
5
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen.新生儿筛查诊断的囊性纤维化婴儿上呼吸道微生物群的发展。
J Cyst Fibros. 2023 Jul;22(4):644-651. doi: 10.1016/j.jcf.2023.04.017. Epub 2023 May 1.
6
Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future.囊性纤维化患者的抗生素耐药性:过去、现在与未来
Antibiotics (Basel). 2023 Jan 20;12(2):217. doi: 10.3390/antibiotics12020217.
7
Impact of Chronic Bronchial Infection by on Bronchiectasis.[病原体名称]慢性支气管感染对支气管扩张的影响。 (注:原文中“by”后面缺少具体病原体名称)
J Clin Med. 2022 Jul 7;11(14):3960. doi: 10.3390/jcm11143960.
8
Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis.微生物群优势的变化与囊性纤维化患者肺功能下降和炎症波动有关。
Front Microbiol. 2022 May 13;13:885822. doi: 10.3389/fmicb.2022.885822. eCollection 2022.
9
An Overview on the Upper and Lower Airway Microbiome in Cystic Fibrosis Patients.囊性纤维化患者上下呼吸道微生物群概述
Tanaffos. 2021 Feb;20(2):86-98.
10
Comparison of the airway microbiota in children with chronic suppurative lung disease.儿童慢性化脓性肺病的气道微生物组比较。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001106.
囊性纤维化患者气道微生物组的年龄与疾病谱特征。
Eur Respir J. 2017 Nov 16;50(5). doi: 10.1183/13993003.00832-2017. Print 2017 Nov.
4
Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.抗生素、气道微生物组与囊性纤维化婴儿炎症的关联。
Ann Am Thorac Soc. 2017 Oct;14(10):1548-1555. doi: 10.1513/AnnalsATS.201702-121OC.
5
Concordance between upper and lower airway microbiota in infants with cystic fibrosis.婴儿囊性纤维化上下呼吸道微生物群落的一致性。
Eur Respir J. 2017 Mar 29;49(3). doi: 10.1183/13993003.02235-2016. Print 2017 Mar.
6
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.早期囊性纤维化肺病患者的下呼吸道微生物组:一项纵向分析。
Thorax. 2017 Dec;72(12):1104-1112. doi: 10.1136/thoraxjnl-2016-209279. Epub 2017 Mar 9.
7
Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.来自临床健康的囊性纤维化婴儿支气管肺泡灌洗中的气道微生物群
PLoS One. 2016 Dec 8;11(12):e0167649. doi: 10.1371/journal.pone.0167649. eCollection 2016.
8
Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.口服抗生素治疗肺部恶化对囊性纤维化临床结局的影响。
Thorax. 2017 Apr;72(4):327-332. doi: 10.1136/thoraxjnl-2016-208450. Epub 2016 Aug 18.
9
Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens.基于培养法和非培养法的囊性纤维化呼吸道标本细菌学分析
J Clin Microbiol. 2016 Mar;54(3):613-9. doi: 10.1128/JCM.02299-15. Epub 2015 Dec 23.
10
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.婴儿期囊性纤维化患者鼻咽微生物组的发育。
Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.